Simplex Trading
CHRS icon

Simplex Trading’s Coherus Oncology CHRS Stock Holding History

Simplex Trading’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Sell
10,820
-33,582
-76% -$54.8K ﹤0.01% 7348
2026
Q1 		$75K Sell
44,402
-3,642
-8% -$6.47K ﹤0.01% 5412
2025
Q4 		$68.2K Sell
48,044
-10,779
-18% -$15.7K ﹤0.01% 5370
2025
Q3 		$96K Buy
58,823
+56,843
+2,871% +$63.2K ﹤0.01% 5788
2025
Q2 		$1K Buy
1,980
+632
+47% +$546 ﹤0.01% 8271
2025
Q1 		$1K Buy
+1,348
New +$1.55K ﹤0.01% 8166
2024
Q4 		– Sell
-11,367
Closed -$12.8K – 8605
2024
Q3 		$11K Sell
11,367
-88,880
-89% -$122K ﹤0.01% 7114
2024
Q2 		$173K Buy
100,247
+83,210
+488% +$167K ﹤0.01% 4793
2024
Q1 		$40K Sell
17,037
-56,001
-77% -$138K ﹤0.01% 6456
2023
Q4 		$243K Buy
73,038
+24,145
+49% +$64.7K ﹤0.01% 4467
2023
Q3 		$182K Sell
48,893
-58,943
-55% -$272K ﹤0.01% 4445
2023
Q2 		$460K Buy
107,836
+94,561
+712% +$558K ﹤0.01% 3397
2023
Q1 		$90K Sell
13,275
-24,140
-65% -$187K ﹤0.01% 5265
2022
Q4 		$296K Buy
37,415
+7,438
+25% +$57.2K ﹤0.01% 3751
2022
Q3 		$288K Sell
29,977
-94,141
-76% -$953K ﹤0.01% 4131
2022
Q2 		$898K Buy
124,118
+122,981
+10,816% +$1.07M ﹤0.01% 2740
2022
Q1 		$14K Sell
1,137
-1,086
-49% -$13.8K ﹤0.01% 8575
2021
Q4 		$35K Buy
2,223
+935
+73% +$16.4K ﹤0.01% 7688
2021
Q3 		$18K Sell
1,288
-800
-38% -$11.7K ﹤0.01% 8510
2021
Q2 		$28K Sell
2,088
-6,680
-76% -$94.6K ﹤0.01% 8283
2021
Q1 		$0 Buy
8,768
+5,411
+161% +$91.9K ﹤0.01% 8925
2020
Q4 		$58K Buy
3,357
+3,231
+2,564% +$57.5K ﹤0.01% 6019
2020
Q3 		$2K Sell
126
-1,229
-91% -$22.9K ﹤0.01% 7397
2020
Q2 		$24K Sell
1,355
-57
-4% -$965 ﹤0.01% 6068
2020
Q1 		$22K Sell
1,412
-3,726
-73% -$68.8K ﹤0.01% 5861
2019
Q4 		$92K Sell
5,138
-11,748
-70% -$217K ﹤0.01% 4593
2019
Q3 		$342K Sell
16,886
-29,670
-64% -$593K ﹤0.01% 3034
2019
Q2 		$1.03M Buy
46,556
+42,593
+1,075% +$740K ﹤0.01% 1872
2019
Q1 		$54K Sell
3,963
-164
-4% -$2.19K ﹤0.01% 4942
2018
Q4 		$37K Sell
4,127
-2,971
-42% -$34.4K ﹤0.01% 4808
2018
Q3 		$117K Sell
7,098
-6,403
-47% -$114K ﹤0.01% 4268
2018
Q2 		$189K Sell
13,501
-332
-2% -$4.75K ﹤0.01% 3554
2018
Q1 		$152K Sell
13,833
-11,140
-45% -$122K 0.01% 1453
2017
Q4 		$219K Buy
24,973
+14,821
+146% +$159K 0.01% 1208
2017
Q3 		$135K Buy
+10,152
New +$134K 0.01% 1480
2017
Q2 		– Sell
-7,417
Closed -$143K – 6150
2017
Q1 		$156K Buy
+7,417
New +$182K 0.01% 1405
2016
Q4 		– Sell
-1,075
Closed -$30.1K – 5882
2016
Q3 		$28K Buy
1,075
+576
+115% +$15.7K ﹤0.01% 2622
2016
Q2 		$8K Buy
499
+372
+293% +$6.98K ﹤0.01% 3784
2016
Q1 		$2K Sell
127
-1,548
-92% -$25.4K ﹤0.01% 4676
2015
Q4 		$38K Buy
1,675
+1,566
+1,437% +$40.3K ﹤0.01% 2136
2015
Q3 		$2K Buy
+109
New +$3.32K ﹤0.01% 4597

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Simplex Trading's CHRS Position: Q2 2026 in Review

Simplex Trading reduced its Coherus Oncology (CHRS) stake by 76% in Q2 2026, selling an estimated $54.8K and leaving 10,820 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7348.

Simplex Trading first reported a position in CHRS in Q3 2015 and has held it in 41 quarters since. The position peaked at $1.03M in Q2 2019. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Simplex Trading held 10,820 shares of Coherus Oncology worth $15.1K as of Q2 2026.
  • Simplex Trading sold 33,582 Coherus Oncology shares in Q2 2026, an estimated $54.8K.
  • Coherus Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7348 holding.
  • Simplex Trading first reported a position in Coherus Oncology in Q3 2015 and has held it in 41 quarters since.
  • Simplex Trading's Coherus Oncology position peaked at $1.03M in Q2 2019.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.